Organizing Drug Users for Community & Social Change.

Slides:



Advertisements
Similar presentations
Sharon Stancliff, MD Caroline Rath, PA-C Harm Reduction Coalition New York, NY USA.
Advertisements

February 2006 WHO's Contribution to Scaling Up towards Universal Access to HIV/AIDS Prevention, Care and Treatment Department of HIV/AIDS.
Saving lives, changing minds. Collaborative TB/HIV services for people who use drugs The experience of Red Cross / Red Crescent Lasha Goguadze.
Consumer Input Into Pharmacotherapy Treatment: Policy: Positive Outcomes Nicole Wiggins CAHMA Manager.
No one left behind: Increased coverage, better programmes and maximum impact for key populations WHO Consolidated Guidelines on HIV Prevention, Diagnosis,
Robin Pollard Operations Coordinator Youth RISE.
The Health in Prisons Programme HIPP of WHO Why does WHO engage in prison health?
WHAI Origins A Provincial HIV Initiative for Women 3.
State of Texas HIV Planning &. Goals for the National HIV/AIDS Strategy 1.Reduce new HIV infections 2.Increase access to care and improve health outcomes.
Out of Sight, Out of Time: Injection Drug Users, Hepatitis C, and HIV Policy Daniel Raymond Hepatitis C Policy Analyst Harm Reduction Coalition
Giving us a global voice Cecilia Chung, USA On behalf of the Key Populations Living with HIV Advisory Group of GNP+
Beyond Treatment: Reframing our Approach to Latino Health in 2011 Presentation by John Hellman, M.A. Director of Advocacy Latino Commission on AIDS March.
Helping People Succeed TRIEC/CASIP Employer Toolbox Joint Initiative Connecting Employers to Solutions for Hiring Skilled Immigrants.
REFERRALS & NETWORKING. WHAT IS NETWORKING? Building linkage and relationship with other individuals /organizations/groups of people Sharing information.
Models of Harm Reduction
Hepatitis C Action Plan Prevention Working Group Findings and recommendations Norah Palmateer Health Protection Scotland Greater Glasgow & Clyde MCN June.
Consumer Participation in HIV Service Planning Quarterly Contractors Meeting May 12, 2010 Jennifer Flannagan ADAP Operations Specialist Virginia Department.
Advocacy and Coalition Building Molly Cole Executive Director FAVOR, Inc. June 29, 2006.
HIV and Hepatitis C in non- MSM Rural Communities: Issues and Interventions Shari Wells-Weiss, CASAC Director of Prevention Services Southern Tier AIDS.
1 How ready are you to change prevention? Preparing an agency for Prevention with Positives.
Edo Agustian Indonesian Drug Users Network Experiencing HCV Infection – the treatment, the reality and the possibilities for Cure.
Hepatitis and Liver Cancer A National Strategy for Prevention and Control of Hepatitis B and C.
Overview of Syringe Exchange Programs New York City Police Academy November 24, 2004.
Incorporating HIV and Viral Hepatitis Testing and Referral into Idaho Drug Court Programs Presented by Idaho Advisory Council on HIV and AIDS, Bebe Thompson,
Introduction to Standard 2: Partnering with consumers Advice Centre Network Meeting Nicola Dunbar October 2012.
HIV/AIDS in Prison Settings Dr. Monica Beg HIV/AIDS Unit, United Nations Office on Drugs and Crime, Krakow, Poland September 27, 2004.
Administrator Checklist Research and Training Center on Service Coordination.
Breaking Down Barriers: Access to HIV Testing and Treatment for San Franciscans Affected by Mental Health and Substance Use Prepared for: HIV Prevention.
Overview of Harm Reduction and Sterile Syringe Access Anna Benyo Syringe Access Policy Coordinator Harm Reduction Coalition New Jersey Syringe Access Informational.
Working with SEPs: How do we expand Hepatitis Services ? Narelle Ellendon, RN HCV Director Harm Reduction Coalition, NYC
HIV/AIDS prevention and care among injecting drug users and in prison settings in Estonia, Latvia and Lithuania Signe ROTBERGA UNODC, Baltic States 5 November.
Milwaukee Partnership to Respond to 2009 EPI AID Study in Milwaukee Brenda Coley Diverse and Resilient, Inc.
Youth Satellite Meeting Sunday, May 13 th The International Youth Network for Harm Reduction.
HIV Treatment and Care Research priorities Facilitator – Dr Saphonn Vonthanak 12 participants 29 agreed topics –not grouped on methodology or subject category.
COUNTRY PRESENTATION (DRUGS AND HIV/AIDS)– Nepal Dr. Krishna Kumar Rai, Director National Centre for AIDS and STD Control, Ministry of Health and Population.
1 Promotoras, Peer Participant Providers and Community Outreach as Preconception in the Continuum of Perinatal HIV Transmission Armida Ayala, M.H.A., Ph.D.
USERS’ INVOLVEMENT IN MENTAL HEALTH WORK. By Sylvester Katontoka
Advocating for Harm Reduction: A Public Health Response to Drug Use and HIV in Eastern Europe and Central Asia Sue Simon International Harm Reduction Development.
TI for IDUs Sexual IDUBlood Perinatal Unidentified Routes of HIV Transmission SENTINEL SURVEILLANCE 2006 HIV infection in India.
A global perspective on scaling up harm reduction 2 nd National Harm Reduction Conference, Ukraine, March 2007 Dr Jos Perriens, Director Prevention.
Care Network of the Treasure Coast.  The mission of the Care Network of the Treasure Coast (CNTC) is to serve as the advisory body for the Ryan White.
Lifting the Federal Ban on the funding of syringe exchange: An advocacy campaign Allan Clear XVIII International AIDS Conference.
21 JUNE 2006 Zimbabwe AIDS Network Presentation ” TAG/TAC AFRICA REGION TB/HIV ADVOCACY WORKSHOP PRESENTATION BY DOMINICA MUDOTA.
STATE OF THE STATE SHELLEY LUCAS HIV/STD PREVENTION & CARE BRANCH DEPT OF STATE HEALTH SERVICES AUGUST 3, 2015.
Greg Gabbert AIDS Alabama NATIONAL & LOCAL CAMPAIGN.
Pennsylvania: The State of HCV 2015
Our Mission To address HIV and the structural factors that impact the lives of young women of color ages in NYC.
Housing, Homelessness and Substance Misuse Recommendations from the Advisory Group.
Prevention of Blood-Borne Pathogen Transmission in Egypt Ministry of Health and Population Arab Republic of Egypt.
Michigan Partners for Freedom1 Building Demand for Self-Determination.
Presidential Executive Order on LGBT Workplace Discrimination.
Clinica Bienestar Philadelphia FIGHT and Prevention Point Philadelphia Laura Bamford, Miguel Munoz-Laboy, Andres Freire, Ana Rose, and Jose Benitez.
Lessons Learned and Novel Investigation Techniques in Response to a Large Community Outbreak of HIV-1 infection Philip J. Peters MD HIV Testing and Biomedical.
IDUHA Hepatitis C Peer Navigation Program Brooklyn Hep C Task Force Meeting Brooklyn Borough Hall March 9, 2016 Viral Hepatitis Surveillance, Prevention.
From evidence to commitment to action: implementing HIV prevention measures in prisons in Ukraine XVI International AIDS Conference Toronto, 15 August.
Organizing Drug Users for Public Health Policy Changes 17 th International Conference on the Reduction of Drug Related Harm Jason Farrell, Executive Director.
IACHA New Member ORIENTATION GUIDE. IACHA BACKGROUND In 1994, Idaho embraced a community planning process to assist in the development of a plan targeting.
Edo Agustian Indonesian Drug Users Network Meaningful Involvement of PWID in Hep C advocacy in Indonesia.
Non-Medical Staff Knowledge, Beliefs and Practices about HIV and Hepatitis for Injection Drug Users Rowe, KA 1, Tesoriero, JM 1, Heavner, KK 1, Rothman,
 The Work of Civil Society in the Field of HIV Prevention Brussels, 23 February 2011 The Work of European AIDS Treatment Group (EATG) 1.
Abstract #TUPDE202: Collaboration and Cross Training between Health and Correctional Services Leads to More Integrated Services for PHAs in Prison: Poster.
Key Population Community taking the Lead.
General Situation (Overview)
Mission: "We have a genuine passion for promoting health and hope without limits for all people through harm reduction.”
National Programme for limiting spread of HIV/AIDS in Latvia 2008–2012
NASTAD Update CSTE Annual Conference
Blood borne viral hepatitis action in Wales
Sustaining Primary Care-Public Health Partnerships for Engagement in Care – The Partnerships for Care Demonstration Project Sue Lin, PhD, MS Director,
Evaluating AETC NCRC Partnerships for Impact
Human Dignity and Harm Reduction
Presentation transcript:

Organizing Drug Users for Community & Social Change

HIV/AIDS in NYC New York City has 20% of the nation's HIV cases and AIDS deaths, highest rates in the US.

HIV Among IDU’s in NYC

Outcomes and Success There has been an 80% reduction in HIV transmission. NYC 1992: 50% of IDUs were HIV positive, 4% infected per year NYC 2002: as few as 18% of IDUs are HIV positive, 1% infected per year

User Unions Dutch Model Australian Model Canadian Model

Mission and Purpose The purpose of Voices of Community Advocates and Leaders (VOCAL), the New York User Union, is to increase the scope of consumer input by involving IDU’s from all New York syringe exchange programs in the development of policies and services that directly affect their lives. VOCAL addresses the current lack of meaningful input that drug injectors mono and co-infected have in the development and implementation of services. Although harm reduction has become widely accepted as an effective public health intervention, drug users continue to be excluded from policy debates and program implementation, in contrast to consumers of traditional AIDS prevention programs.

Advisory Committees National HCAP National Viral Hepatitis Round Table National HIV/HCV Co- Infection Coalition Care Coalition Pharmaceutical Community Meetings State/City HIV Prevention Planning Group – City and State New York City Ryan White Planning Council New York Hepatitis Network New York State Viral Hepatitis Planning Committee IDUHA

Advisory Committees National HCAP National Viral Hepatitis Round Table National HIV/HCV Co- Infection Coalition Care Coalition Pharmaceutical Community Meetings State/City HIV Prevention Planning Group – City and State New York City Ryan White Planning Council New York Hepatitis Network New York State Viral Hepatitis Planning Committee IDUHA

User Organizing Trusting relationship with consumers/drug injectors Involvement with other advisory and planning bodies Network with other agencies that serve drug injectors Resources for transportation and food Facilitate IDU leadership Flexibility in meeting days and times Advocacy trainings Access to current HCV/HIV medical information

User Organizing Building leadership from all NYC syringe exchange programs; considering forming chapters at each SEP or borough Trainings to develop organizing and advocacy skills among our members General membership meetings on the last Wednesday of every month Steering committee meetings every 2 nd and 4 th Tuesday of the month Committees: Housing, Health Care Access, Drug Policy Reform, and Prison Health User-led HCV support group every Thursday Syringe distribution (ESAP) every Tuesday and Thursday

Desired Outcomes HCV care network to ensure citywide continuum of care Policy and service delivery changes to accommodate IDU needs regarding treatment care, adherence and support services Training for IDU's to become better advocates Participation and placement on committees that allow IDU's to monitor and develop prevention messages and service provision

Current Campaigns “Syringes in the Shelters” Right of Return to Public Housing

For more information about VOCAL/NY Users Union please contact: Louis Jones, VOCAL Coordinator | (718) x 18 Jeremy Saunders, VOCAL Organizer | (718) x16 Web: